Innorna Nominated for 2026 Prix Galien USA Best Startup Award

Contributed by: PR Newswire

Images

PR Newswire associated0

Tags

Innorna-Prix-Award

More Like This

PR Newswire associated0

Innorna Announces FDA Clearance of IND for IN026, Advancing mRNA-based Therapies into Chronic Metabolic Diseases

Innorna Announces FDA Rare Pediatric Disease and Orphan Drug Designations Granted to IN013 for Treatment of Wilson Disease

INNORNA Completes Phase II Enrollment and Vaccination of Bivalent RSV mRNA Vaccine IN006

PR Newswire associated0

Rona Therapeutics Advances INHBE siRNA Into Phase 1 Clinical Development

PR Newswire associated0

Rona Therapeutics Advances INHBE siRNA Into Phase 1 Clinical Development

Rona Therapeutics Announces IND Filing of RN3161, a Highly Potent and Durable INHBE siRNA for Obesity

François Ravenelle, PhD, President and Chief Executive Officer of Innospera Pharma

François Ravenelle, PhD Appointed President and CEO of Innospera Pharma to Lead Next Phase of Growth

Rona Therapeutics Announces Breakthrough Data on Potential Annual Dosing RNAi Therapy RN026 Targeting Lipoprotein(a) in The National Lipid Association (NLA) Scientific Sessions 2025